The Formulary Management Expert Committee (FMEC) recommends that pertuzumab in combination with trastuzumab and chemotherapy be reimbursed for the treatment […]
Post Content
Traditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) is a pragmatic, randomized trial that primarily evaluates whether, in early
Tools that leverage machine learning, a subset of artificial intelligence, are becoming increasingly important for conducting evidence synthesis as the
Pharmacy plays a critical role in improving patient outcomes and strengthening health systems. In May 2025, the National Academies convened
The aims of this investigation are
The U.S. medicolegal death investigation system is responsible for investigating and providing determinations of cause and manner of death, playing
Post Content
Multiple sclerosis (MS) is a common cause of neurological disability among young and middle-aged people, most often with a relapsing-remitting
Registries, network databases, and the electronic health record commonly impose a hierarchical structure in which patients are clustered in ways
Registration No: 771800548 Contact Number : +91-8249516996
